The OpEd article below was originally published in The PJ Tatler on Nov 14th. To read the OpEd click HERE. LabMD, a company that diagnoses cancer for physicians, is waging a true David vs. Goliath battle with the Federal Trade Commission. It is simple, clean and vicious, and LabMD is finally taking a pound of flesh […]
Saturday October 18th at Manuel’s Tavern at 2pm Michael Daugherty, author and CEO of the cancer testing facility LabMD in Atlanta will be chronicling his battle with the Federal Trade Commission after disputing Tiversa Inc.’s allegations of 9000 of LabMD’s patients being available on peer-to-peer networks. Tiversa required a services agreement to give LabMD any […]
LabMD and Michael Daughterty made the HIPAA, HITECH & HIT this week! Elizabeth Litten, esq., of the firm Fox Rothschild, writes in her article dated Oct 15th, about the recent news regarding the FTC vs LabMD case. Read below about allegations that the LabMD file was never anywhere but the LabMD computer until Tiversa took […]
Postponed till Mid November – Stay tuned for more information! What promises to be an insightful session is scheduled for: September 17, 2014 | 10:00 a.m. in 2154 Rayburn House Office Building If you are in the area, join Michael in learning what the committee will uncover. If you aren’t in the area, this session […]
The Eleventh Circuit has announced that they are going to hold oral arguments in LabMD’s case even though the appellate court had refused. See below for Law 360’s reporting of this development. To view the original article, click HERE. The Eleventh Circuit said Wednesday that it has decided to hold oral arguments on LabMD Inc.’s latest […]
Michael Daugherty is President & CEO of LabMD, an Atlanta-based clinical and anatomic medical laboratory with a national client base. Read more...